date,title,source
Oct-19-18,"Detailed Research: Economic Perspectives on W.W. Grainger, Jabil, Grand Canyon Education, Sage Therapeutics, H. B. Fuller, and Jazz Pharmaceuticals  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
Oct-23-18,"Sage Therapeutics to Report Third Quarter 2018 Financial Results on Tuesday, November 6, 2018",Business Wire
Oct-24-18,Today's Research Reports on Trending Tickers: Sage Therapeutics and Ionis Pharmaceuticals,ACCESSWIRE
Oct-25-18,Cramer's lightning round: 'Take the money and run' with takeover stock Mazor Robotics,CNBC
Oct-26-18,Sage Therapeutics Turned Down - Don't Rush to Be a Buyer,TheStreet.com
Oct-29-18,FDA set to review new drugs aimed at fighting depression,CNBC Videos
Oct-31-18,Today's Research Reports on Trending Tickers: Exelixis and Sage Therapeutics,ACCESSWIRE
Nov-05-18,Todays Research Reports on Stocks to Watch: AcelRx Pharmaceuticals and Sage Therapeutics,ACCESSWIRE
Nov-05-18,Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),Business Wire
Nov-06-18,Edited Transcript of SAGE earnings conference call or presentation 6-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-06-18,Sage Therapeutics Announces Third Quarter 2018 Financial Results and Highlights Pipeline and Business Progress,Business Wire
Nov-07-18,Sage Therapeutics to Present at Stifel 2018 Healthcare Conference,Business Wire
Nov-12-18,"Stocks making the biggest moves after hours: PG&E, Eventbrite and more",CNBC
Nov-16-18,Today's Research Reports on Trending Tickers: Sarepta Therapeutics and Sage Therapeutics,ACCESSWIRE
Nov-20-18,Sage Therapeutics Receives Notification of PDUFA Extension for ZULRESSO (brexanolone) Injection,Business Wire
Nov-21-18,Sage Therapeutics to Present at Piper Jaffray 30th Annual Healthcare Conference,Business Wire
Nov-26-18,Today's Research Reports on Trending Tickers: GW Pharmaceuticals and Sage Therapeutics,ACCESSWIRE
Nov-29-18,"New Research: Key Drivers of Growth for Upland Software, VICI Properties, Sage Therapeutics, Jack Henry & Associates, T2 Biosystems, and Tata Motors  Factors of Influence, Major Initiatives and Sustained Production",GlobeNewswire
Nov-30-18,Today's Research Reports on Trending Tickers: Alnylam Pharmaceuticals and Sage Therapeutics,ACCESSWIRE
Dec-10-18,Hedge Funds Are Selling SAGE Therapeutics Inc (SAGE),Insider Monkey
Dec-12-18,Here's Why Marinus Pharmaceuticals Is Sinking Today,Motley Fool
Dec-14-18,Today's Research Reports on Trending Tickers: Sage Therapeutics and Altimmune,ACCESSWIRE
Dec-20-18,"DAFNA Capital Management Return, AUM and Holdings",Insider Monkey
Dec-20-18,"Has Sage Therapeutics, Inc. (NASDAQ:SAGE) Got Enough Cash?",Simply Wall St.
Dec-24-18,Biotech Buying Spree: Why These 3 Stocks Could Get Deals In 2019,Investor's Business Daily
Dec-27-18,"Sage Therapeutics to Present at J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019",Business Wire
Jan-03-19,Implied Volatility Surging for Sage Therapeutics (SAGE) Stock Options,Zacks
Jan-04-19,Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),Business Wire
Jan-07-19,Biotech Stocks Post Double-Digit Gains in Monday Surge,TheStreet.com
Jan-07-19,What Happened in the Stock Market Today,Motley Fool
Jan-07-19,Sage Therapeutics's stock shoots higher after postpartum depression treatment's positive trial results,MarketWatch
Jan-07-19,Why Sage Therapeutics Is Skyrocketing Today,Motley Fool
Jan-07-19,SAGE Therapeutics Soars on Promising Postpartum Drug-Trial Results,TheStreet.com
Jan-07-19,"Report: Developing Opportunities within General Mills, Philip Morris International, Sage Therapeutics, CNA Financial, Hess, and AutoNation  Future Expectations, Projections Moving into 2019",GlobeNewswire
Jan-07-19,Sage Therapeutics to Provide Update on Key 2019 Initiatives at J.P. Morgan Healthcare Conference,Business Wire
Jan-07-19,Today's Research Reports on Trending Tickers: Amarin Corporation and Sage Therapeutics,ACCESSWIRE
Jan-07-19,Pill for postpartum depression by Cambridge's Sage succeeds in late-stage trial,American City Business Journals
Jan-07-19,Sage's oral postpartum depression treatment succeeds in late-stage study,Reuters
Jan-07-19,Sage Therapeutics Announces SAGE-217 Meets Primary and Secondary Endpoints in Phase 3 Clinical Trial in Postpartum Depression,Business Wire
Jan-08-19,Here's Why Axsome Therapeutics Has Been a Rocket Ship This Week,Motley Fool
